NO996514L - Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom - Google Patents
Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av LymesykdomInfo
- Publication number
- NO996514L NO996514L NO996514A NO996514A NO996514L NO 996514 L NO996514 L NO 996514L NO 996514 A NO996514 A NO 996514A NO 996514 A NO996514 A NO 996514A NO 996514 L NO996514 L NO 996514L
- Authority
- NO
- Norway
- Prior art keywords
- diagnosis
- lyme disease
- prevention
- compositions
- surface antigens
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 208000016604 Lyme disease Diseases 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 241000908522 Borreliella Species 0.000 abstract 3
- 241000589970 Spirochaetales Species 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 2
- 241000589968 Borrelia Species 0.000 abstract 1
- 101100108136 Drosophila melanogaster Adck1 gene Proteins 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Et nytt isoler Borrelia burgdorferi sensu lato overflateantigen er karakterisert med en relativ molekylmasse på 39,5 kDa. Dette antigenet blir uttrykt in vitro av spirocheter fra en B. burgdorferi sensu lato stamme. Dette antigenet induserer antistoffer som avliver spirocheter fra en B. burgdorferi sensu lato stamme med ADCK in vitro. Nytt Borrelia kassettstrengprotein eller fragmenter derav er også nyttige, det er også P39.5 protein i diagnostisering av Lyme sykdom og i sammensetning for behandling av profylakse derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5127197P | 1997-06-30 | 1997-06-30 | |
PCT/US1998/013551 WO1999000413A1 (en) | 1997-06-30 | 1998-06-29 | Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
Publications (2)
Publication Number | Publication Date |
---|---|
NO996514D0 NO996514D0 (no) | 1999-12-28 |
NO996514L true NO996514L (no) | 2000-02-14 |
Family
ID=21970280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO996514A NO996514L (no) | 1997-06-30 | 1999-12-28 | Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom |
Country Status (17)
Country | Link |
---|---|
US (2) | US6660274B2 (no) |
EP (1) | EP1012181B1 (no) |
JP (1) | JP2002511760A (no) |
KR (1) | KR20010020567A (no) |
CN (1) | CN1261896A (no) |
AR (1) | AR016295A1 (no) |
AT (1) | ATE337335T1 (no) |
AU (1) | AU8177298A (no) |
CA (1) | CA2294701C (no) |
CO (1) | CO4790101A1 (no) |
DE (1) | DE69835682T2 (no) |
DK (1) | DK1012181T3 (no) |
ES (1) | ES2270523T3 (no) |
NO (1) | NO996514L (no) |
PL (1) | PL337667A1 (no) |
WO (1) | WO1999000413A1 (no) |
ZA (1) | ZA985704B (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0894143B2 (en) * | 1996-02-21 | 2012-04-18 | Board Of Regents, The University Of Texas System | Vmp-like sequences of pathogenic borrelia |
WO1999000413A1 (en) * | 1997-06-30 | 1999-01-07 | The Administrators Of The Tulane Educational Fund | Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
US6475492B1 (en) * | 1999-04-28 | 2002-11-05 | The Administrators Of The Tulane Educational Fund | Peptides and assays for the diagnosis of lyme disease |
EP1572714A4 (en) | 2002-12-20 | 2006-08-09 | Univ Texas | SEQUENCES OF SPECIES AND STRAINS OF I BORRELIA / I PATHOGENIC VMP TYPE |
WO2007133623A2 (en) * | 2006-05-10 | 2007-11-22 | Biopeptides Corporation | Peptide diagnostic agent for lyme disease |
WO2008057396A2 (en) | 2006-11-03 | 2008-05-15 | Schering-Plough Ltd. | Canine lyme disease vaccine |
ES2337113B1 (es) * | 2007-04-17 | 2011-01-24 | Centre De Recerca En Sanitat Animal (Cresa) | Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante. |
US8247181B2 (en) * | 2007-09-07 | 2012-08-21 | The Regents Of The University Of California | Borrelia diagnostics and screening methods |
WO2010132758A2 (en) * | 2009-05-14 | 2010-11-18 | Gomes-Solecki Maria J | Ospc-based diagnostic test for lyme disease |
WO2011063003A2 (en) | 2009-11-17 | 2011-05-26 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
SI2569008T1 (sl) * | 2010-05-14 | 2020-02-28 | Baxalta Incorporated | Himere OSPA in njihova uporaba v cepivih |
CA2812759A1 (en) | 2010-09-27 | 2012-04-12 | Cornell University | Methods for diagnosing lyme disease |
WO2013067448A2 (en) | 2011-11-03 | 2013-05-10 | Vca Antech Inc. | Compositions and methods to detect various infectious organisms |
US8758772B2 (en) | 2011-11-04 | 2014-06-24 | Abaxis, Inc. | Peptides and methods for the detection of lyme disease antibodies |
US9670537B2 (en) | 2014-06-06 | 2017-06-06 | Titan Collaborative Kithe, Llc | Borrelia Provocation Procedure kit |
US11061028B2 (en) | 2014-09-24 | 2021-07-13 | Defined Diagnostics, Llc | Compositions and methods for the diagnosis of lyme disease |
JP2018526645A (ja) | 2015-08-27 | 2018-09-13 | クイデル コーポレーション | 2つ以上の分析物の検出および区別のための2つの流体流路を有する免疫アッセイ試験装置 |
CN106432487A (zh) * | 2016-10-31 | 2017-02-22 | 杭州贝英福生物科技有限公司 | 一种伽氏疏螺旋体多克隆抗体及应用 |
CN106397589A (zh) * | 2016-10-31 | 2017-02-15 | 杭州贝英福生物科技有限公司 | 一种狭义伯氏疏螺旋体多克隆抗体及应用 |
US11446654B2 (en) | 2017-02-10 | 2022-09-20 | Quidel Corporation | Substrate with channels for controlled fluid flow |
CN109596824A (zh) * | 2019-01-04 | 2019-04-09 | 杭州奥泰生物技术股份有限公司 | 一种快速诊断莱姆病的检测试纸及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US485551A (en) | 1892-11-01 | And william | ||
DK590288D0 (da) * | 1988-10-24 | 1988-10-24 | Symbicom Ab | Kemiske forbindelser |
EP0339695A3 (en) | 1988-04-29 | 1990-05-30 | Stichting Voor De Technische Wetenschappen | A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates |
ES2092560T5 (es) | 1989-12-22 | 2004-09-16 | Mikrogen Molekularbiologische Entwicklungs-Gmbh | Proteinas inmunologicamente activas de borrelia burgdorferi, estuches de ensayo relacionados y vacuna. |
US5217872A (en) * | 1990-02-27 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Method for detection of borrelia burgdorferi antigens |
EP0524958B1 (en) | 1990-03-05 | 1996-09-18 | THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE | Antigenic proteins of borrelia burgdorferi |
WO1992000055A1 (en) | 1990-06-15 | 1992-01-09 | Yale University | Compositions and methods for the prevention and diagnosis of lyme disease |
EP1016416A3 (en) | 1990-07-06 | 2002-10-23 | Wyeth | Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy |
EP0894143B2 (en) * | 1996-02-21 | 2012-04-18 | Board Of Regents, The University Of Texas System | Vmp-like sequences of pathogenic borrelia |
DE19632862B4 (de) * | 1996-08-14 | 2006-08-03 | Mikrogen Molekularbiologische Entwicklungs-Gmbh | Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe |
WO1999000413A1 (en) * | 1997-06-30 | 1999-01-07 | The Administrators Of The Tulane Educational Fund | Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
US6475492B1 (en) * | 1999-04-28 | 2002-11-05 | The Administrators Of The Tulane Educational Fund | Peptides and assays for the diagnosis of lyme disease |
-
1998
- 1998-06-29 WO PCT/US1998/013551 patent/WO1999000413A1/en active IP Right Grant
- 1998-06-29 PL PL98337667A patent/PL337667A1/xx unknown
- 1998-06-29 AT AT98931729T patent/ATE337335T1/de active
- 1998-06-29 DK DK98931729T patent/DK1012181T3/da active
- 1998-06-29 JP JP50587199A patent/JP2002511760A/ja active Pending
- 1998-06-29 KR KR1019997012472A patent/KR20010020567A/ko not_active Application Discontinuation
- 1998-06-29 DE DE69835682T patent/DE69835682T2/de not_active Expired - Lifetime
- 1998-06-29 US US09/445,803 patent/US6660274B2/en not_active Expired - Lifetime
- 1998-06-29 CN CN98806699A patent/CN1261896A/zh active Pending
- 1998-06-29 AU AU81772/98A patent/AU8177298A/en not_active Abandoned
- 1998-06-29 CA CA002294701A patent/CA2294701C/en not_active Expired - Lifetime
- 1998-06-29 ES ES98931729T patent/ES2270523T3/es not_active Expired - Lifetime
- 1998-06-29 EP EP98931729A patent/EP1012181B1/en not_active Expired - Lifetime
- 1998-06-30 ZA ZA985704A patent/ZA985704B/xx unknown
- 1998-06-30 CO CO98036847A patent/CO4790101A1/es unknown
- 1998-06-30 AR ARP980103181A patent/AR016295A1/es unknown
-
1999
- 1999-12-28 NO NO996514A patent/NO996514L/no not_active Application Discontinuation
-
2003
- 2003-08-01 US US10/632,780 patent/US20040067517A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69835682T2 (de) | 2007-08-23 |
KR20010020567A (ko) | 2001-03-15 |
ATE337335T1 (de) | 2006-09-15 |
US20040067517A1 (en) | 2004-04-08 |
EP1012181B1 (en) | 2006-08-23 |
CA2294701C (en) | 2009-09-08 |
US20030059894A1 (en) | 2003-03-27 |
ZA985704B (en) | 1999-01-13 |
WO1999000413A1 (en) | 1999-01-07 |
DK1012181T3 (da) | 2007-01-02 |
PL337667A1 (en) | 2000-08-28 |
EP1012181A1 (en) | 2000-06-28 |
US6660274B2 (en) | 2003-12-09 |
JP2002511760A (ja) | 2002-04-16 |
AR016295A1 (es) | 2001-07-04 |
DE69835682D1 (de) | 2006-10-05 |
CO4790101A1 (es) | 1999-05-31 |
CA2294701A1 (en) | 1999-01-07 |
ES2270523T3 (es) | 2007-04-01 |
NO996514D0 (no) | 1999-12-28 |
CN1261896A (zh) | 2000-08-02 |
AU8177298A (en) | 1999-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO996514L (no) | Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom | |
CY1117387T1 (el) | ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ | |
BR9714160A (pt) | Antìgenos uspa1 e uspa2 de moraxella catarrhalis | |
WO2005056600A3 (en) | Monoclonal antibodies that bind or neutralize dengue virus | |
ATE165395T1 (de) | Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen | |
BRPI0408085A (pt) | composição e método para o tratamento e prevenção de infecções entéricas bacterianas | |
WO2000077216A3 (en) | Porcine circovirus vaccine in recombinant poxvirus | |
BR9610872A (pt) | Proteìna receptora de transferrina de moraxella | |
ATE430200T1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
ATE453403T1 (de) | Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert | |
EP1731166A3 (en) | Streptococcus pneumoniae proteins and vaccines | |
WO2003083485A3 (en) | Protein for use in hypoxia related conditions | |
AU2001276619A1 (en) | Immunisation against chlamydia pneumoniae | |
EP0683234A4 (en) | ANTIBODIES DIRECTED AGAINST -g (b) -AMYLOID OR A DERIVATIVE THEREOF AND ITS USE. | |
EP0090581A3 (en) | Small peptides with the specificity of foot and mouth disease viral antigens | |
DE60036698D1 (de) | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen | |
BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
UA42040C2 (uk) | Поліпептид, спосіб діагностики інсулінозалежного цукрового діабету (iddm), що розвинувся або що розвивається (варіанти), набір для діагностики iddm (варіанти), препарат для запобігання або лікування iddm, фармацевтична композиція для профілактики або лікування iddm | |
NO331277B1 (no) | Farmasoytisk sammensetning omfattende polypetid/nukleinsyre for behandling av retinale degenererende sykdommer, vektor, isolert polypeptid, renset antistoff og anvendelse av polypeptid, nukleinsyre og antistoff, samt fremgangsmater og kit | |
ATE142888T1 (de) | Antigen-wirkende proteine von borrelia burgdorferi | |
DE69737323D1 (de) | Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet | |
BR0207528A (pt) | Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo | |
DE69233311D1 (de) | Weidelgraspollen-allergen | |
AU2002310474A1 (en) | Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same | |
PT868522E (pt) | Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |